These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25696994)

  • 1. [Aberrant expression of sox2 gene in malignant gliomas].
    Volnitskiĭ AV; Semenova EV; Shtam TA; Kovalev RA; Filatov MV
    Tsitologiia; 2014; 56(7):504-10. PubMed ID: 25696994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. THE ANALYSIS OF LGI1 GENE EPIGENETIC ALTERATIONS BY MEANS OF POSTTRANSLATIONAL H3 HISTONE MODIFICATIONS IN MALIGNANT GLIOMAS.
    Semenova EV; Volnitsky AV; Filatov MV
    Tsitologiia; 2016; 58(5):335-9. PubMed ID: 30188624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic and epigenetic markers of gliomas].
    Semenova EV; Filatov MV
    Tsitologiia; 2013; 55(5):290-9. PubMed ID: 24592735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX2 expression and amplification in gliomas and glioma cell lines.
    Annovazzi L; Mellai M; Caldera V; Valente G; Schiffer D
    Cancer Genomics Proteomics; 2011; 8(3):139-47. PubMed ID: 21518820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.
    Stoltz K; Sinyuk M; Hale JS; Wu Q; Otvos B; Walker K; Vasanji A; Rich JN; Hjelmeland AB; Lathia JD
    Neuro Oncol; 2015 Mar; 17(3):361-71. PubMed ID: 25416826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas.
    Alonso MM; Diez-Valle R; Manterola L; Rubio A; Liu D; Cortes-Santiago N; Urquiza L; Jauregi P; Lopez de Munain A; Sampron N; Aramburu A; Tejada-Solís S; Vicente C; Odero MD; Bandrés E; García-Foncillas J; Idoate MA; Lang FF; Fueyo J; Gomez-Manzano C
    PLoS One; 2011; 6(11):e26740. PubMed ID: 22069467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
    Zhao B; Bian EB; Li J; Li J
    J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forced expression of Sox21 inhibits Sox2 and induces apoptosis in human glioma cells.
    Ferletta M; Caglayan D; Mokvist L; Jiang Y; Kastemar M; Uhrbom L; Westermark B
    Int J Cancer; 2011 Jul; 129(1):45-60. PubMed ID: 20824710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA‑21 promotes migration and invasion of glioma cells via activation of Sox2 and β‑catenin signaling.
    Luo G; Luo W; Sun X; Lin J; Wang M; Zhang Y; Luo W; Zhang Y
    Mol Med Rep; 2017 Jan; 15(1):187-193. PubMed ID: 27909726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The significance of histone modifications in malignant transformation].
    Gomulak P; Błasiak J
    Postepy Biochem; 2012; 58(3):292-301. PubMed ID: 23373415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in chromatin machinery and pediatric high-grade glioma.
    Lulla RR; Saratsis AM; Hashizume R
    Sci Adv; 2016 Mar; 2(3):e1501354. PubMed ID: 27034984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics in human gliomas.
    Kreth S; Thon N; Kreth FW
    Cancer Lett; 2014 Jan; 342(2):185-92. PubMed ID: 22531315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
    Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
    Herranz M; Esteller M
    Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Smad"eningly erratic: target gene methylation determines whether TGFbeta promotes or suppresses malignant glioma.
    Kesari S; Jackson-Grusby L; Stiles CD
    Dev Cell; 2007 Mar; 12(3):324-5. PubMed ID: 17336898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone onco-modifications.
    Füllgrabe J; Kavanagh E; Joseph B
    Oncogene; 2011 Aug; 30(31):3391-403. PubMed ID: 21516126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global DNA Methylation Patterns in Human Gliomas and Their Interplay with Other Epigenetic Modifications.
    J Dabrowski M; Wojtas B
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31311166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch inhibition via micro-RNA blocks glioma development.
    Berry N; Gursel DB; Boockvar JA
    Neurosurgery; 2012 Apr; 70(4):N20-2. PubMed ID: 22426058
    [No Abstract]   [Full Text] [Related]  

  • 19. The histone deacetylase SIRT6 suppresses the expression of the RNA-binding protein PCBP2 in glioma.
    Chen X; Hao B; Liu Y; Dai D; Han G; Li Y; Wu X; Zhou X; Yue Z; Wang L; Cao Y; Liu J
    Biochem Biophys Res Commun; 2014 Mar; 446(1):364-9. PubMed ID: 24607900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.
    Ding X; He Z; Zhou K; Cheng J; Yao H; Lu D; Cai R; Jin Y; Dong B; Xu Y; Wang Y
    J Natl Cancer Inst; 2010 Jul; 102(14):1052-68. PubMed ID: 20554944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.